NCI is the nation's leader in cancer research
The work of NCI’s FusOnc2 Consortium may one day lead to new treatments for children with cancer.
The gene-editing tool is moving out of lab dishes and into cancer patients.
Learn about NCI’s COVID-19 research efforts and find guidance for cancer researchers whose work is affected by the pandemic.
Learn how CCDI is working to increase data use and sharing to improve outcomes for young people with cancer.
NCI's RAS Initiative explores innovative approaches for attacking the proteins encoded by mutant forms of the KRAS gene.
